3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Pancreatic Ductal
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Gemcitabine
2
selinexor
1
ponatinib
1
neratinib
1
folfirinox
1
contrast agent BR1
1
cobimetinib
1
ceritinib
1
brigatinib
1
abemaciclib
1
Urination
1
S 1 (combination)
1
Radiotherapy
1
Radiosurgery
1
Practice Guidelines as Topic
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxaliplatin
1
Long Interspersed Nucleotide Elements
1
Laparoscopy
1
Irinotecan
1
Immunotherapy, Adoptive
1
Floxuridine
1
Etoposide
1
Endosonography
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Drug Therapy
1
Doxorubicin
1
Colchicine
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Pancreatic Ductal
×
Long Interspersed Nucleotide Elements
×
Clear all
NCT05475366
2026-05-01
PACsign
Institut Curie
Phase NA
Recruiting
85 enrolled